BÍLOVEC – Authorities in the Czech Republic have launched a major criminal investigation into an alleged network of illegal abortions involving foreign patients and local medical professionals. Police detained a gynecologist and charged additional suspects, accusing them of systematically bypassing medical regulations and profiting from cross-border demand. For more global coverage, visit https://www.liveworldupdates.com/.
Cross-border medical tourism under scrutiny
Investigators say a clinic in the town of Bílovec, in the Moravian-Silesian region, offered pregnancy termination procedures to women who were not Czech citizens. Many reportedly traveled from countries with stricter abortion laws, particularly Poland, where regulations are among the most restrictive in the European Union.
Authorities claim the clinic operated a Polish-language website encouraging patients to seek services in the Czech Republic. The services allegedly included both surgical procedures and abortion medication distributed through intermediaries. Prosecutors suspect the system was organized and financially motivated rather than based solely on legitimate medical care.
A 62-year-old gynecologist was arrested on February 19 and placed in custody. Two additional suspects were charged but remain free while under investigation. All face potential prison sentences ranging from two to eight years, as well as revocation of their medical licenses.
Legal framework and alleged violations
In the Czech Republic, abortion is legal up to the 12th week of pregnancy under defined medical conditions and informed consent requirements. After that period, it is permitted only for serious medical reasons. Authorities are now examining whether the clinic ignored waiting periods, medical consultations, or documentation rules.
One suspect is additionally accused of misleading patients and concealing relevant medical information during consultations — a factor that could significantly aggravate legal consequences.
A broader European issue
The case highlights a growing phenomenon across Europe: cross-border reproductive healthcare. When national laws differ significantly, patients often travel abroad to access procedures. While legal in many circumstances, experts warn such movement can create gray zones where commercial actors exploit legal differences.
Investigators are currently determining how many women were involved and whether financial intermediaries coordinated travel and appointments. Further charges remain possible as authorities analyze records and communications.